The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 randomized study of isatuximab (Isa) plus lenalidomide and dexamethasone (Rd) with bortezomib versus isard in patients with newly diagnosed transplant ineligible multiple myeloma (NDMM TI).
 
Xavier P. Leleu
No Relationships to Disclose
 
Cyrille Hulin
No Relationships to Disclose
 
Jerome Lambert
No Relationships to Disclose
 
Arthur Bobin
No Relationships to Disclose
 
Salomon Manier
No Relationships to Disclose
 
Aurore Perrot
No Relationships to Disclose
 
Arnaud Jaccard
No Relationships to Disclose
 
Lydia Montes
No Relationships to Disclose
 
Lionel Karlin
No Relationships to Disclose
 
Pascal Godmer
No Relationships to Disclose
 
Thomas Chalopin
No Relationships to Disclose
 
Borhane Slama
No Relationships to Disclose
 
Kamel Laribi
No Relationships to Disclose
 
Marie-Lorraine Chretien
No Relationships to Disclose
 
Mohamad Mohty
No Relationships to Disclose
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Takeda
Research Funding - Sanofi (Inst)
 
Philippe Moreau
No Relationships to Disclose
 
Herve Avet-Loiseau
No Relationships to Disclose
 
Jill Corre
No Relationships to Disclose
 
Thierry Facon
No Relationships to Disclose